An AI strategy for identifying new immunotherapy targets

Researchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI). This is the first peer-reviewed publication from the two organizations’ Discovery Accelerator partnership, designed to advance research in health care and life sciences.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart